Global challenges in left ventricular assist device therapy: a tale across two continents
- PMID: 35670080
- DOI: 10.1002/ejhf.2570
Global challenges in left ventricular assist device therapy: a tale across two continents
Comment on
-
Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry.Eur J Heart Fail. 2022 Jul;24(7):1305-1315. doi: 10.1002/ejhf.2526. Epub 2022 May 24. Eur J Heart Fail. 2022. PMID: 35508920
References
-
- Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, et al.; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device. N Engl J Med. 2019;380:1618-27.
-
- Mehra MR, Gustafsson F. Left ventricular assist devices at the crossroad of innovation in advanced heart failure. J Card Fail. 2021;27:1291-4.
-
- Lim HS, Shaw S, Carter AW, Jayawardana S, Mossialos E, Mehra MR. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: a United Kingdom perspective. J Heart Lung Transplant. 2022;41:174-86.
-
- Molina EJ, Shah P, Kiernan MS, Cornwell WK 3rd, Copeland H, Takeda K, et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann Thorac Surg. 2021;111:778-92.
-
- Mehra MR. Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable. Eur J Heart Fail. 2019;21:98-100.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical